Atom Investors LP Kal Vista Pharmaceuticals, Inc. Transaction History

Atom Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.35 - $12.49 $466,826 - $563,348	-45,104 Reduced 69.39%	19,901 $234,000
Q1 2024 May 15, 2024	SELL	$11.07 - $16.04 $53,567 - $77,617	-4,839 Reduced 6.93%	65,005 $770,000
Q4 2023 Feb 14, 2024	BUY	$7.58 - $12.25 $34,549 - $55,835	4,558 Added 6.98%	69,844 $855,000
Q3 2023 Nov 14, 2023	BUY	$8.95 - $11.35 $283,956 - $360,101	31,727 Added 94.54%	65,286 $628,000
Q2 2023 Aug 14, 2023	BUY	$7.73 - $10.57 $84,836 - $116,005	10,975 Added 48.6%	33,559 $302,000
Q1 2023 May 15, 2023	BUY	$6.3 - $8.39 $142,279 - $189,479	22,584 New	22,584 $177,000

127

48.2M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $226M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.